title: Response to bortezomib of a patient with scleromyxedema refractory to other therapies.
authors.forename: Magdalini
authors.initials: M
authors.lastname: Migkou
authors.forename: Maria
authors.initials: M
authors.lastname: Gkotzamanidou
authors.forename: Evangelos
authors.initials: E
authors.lastname: Terpos
authors.forename: Meletios A
authors.initials: MA
authors.lastname: Dimopoulos
authors.forename: Efstathios
authors.initials: E
authors.lastname: Kastritis
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D011719:Pyrazines / Q000627:therapeutic use*; D016879:Salvage Therapy; D053718:Scleromyxedema / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D007166:Immunosuppressive Agents; D011719:Pyrazines; D000069286:Bortezomib